← The Wire
EWNYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · CIK 1099800
Edwards Lifesciences develops innovative structural heart and critical care technologies to improve patient lives
red 8-K · 90d🔥 High media attention
$49.01B
Market cap
$91.18
Last close
+0.4%
1D
+6.2%
5D
3.6M
Volume
Price · last 39 sessions+9.4%
May 4L $77.17 · H $91.18Jun 29
130
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
11-K11-KJun 12, 202611-K11-KJun 12, 20268-KExecutive Change · Shareholder VoteMay 8, 202610-Q10-QMay 6, 20268-KExecutive Change · Reg FD DisclosureMay 4, 20268-KResults of OperationsApr 23, 2026DEFA14ADEFA14AMar 26, 2026DEFA14ADEFA14AMar 26, 2026DEF 14ADEF 14AMar 26, 202610-K10-KFeb 25, 20268-KResults of OperationsFeb 10, 20268-KReg FD DisclosureJan 12, 202610-Q10-QNov 5, 20258-KExecutive Change · Reg FD DisclosureOct 30, 20258-KResults of OperationsOct 30, 20258-KCompany UpdateAug 19, 202510-Q10-QAug 6, 20258-KReg FD DisclosureAug 6, 20258-KExecutive ChangeJul 25, 20258-KResults of OperationsJul 24, 202511-K11-KJun 17, 202511-K11-KJun 17, 20258-KExecutive Change · Shareholder VoteMay 8, 202510-Q10-QMay 6, 20258-KResults of OperationsApr 23, 2025DEFA14ADEFA14AApr 14, 2025DEFA14ADEFA14AMar 26, 2025DEFA14ADEFA14AMar 26, 2025DEF 14ADEF 14AMar 26, 202510-K10-KFeb 28, 20258-KResults of OperationsFeb 11, 2025SC 13GSEC SCHEDULE 13GNov 8, 202410-Q10-QNov 6, 20248-KResults of OperationsOct 24, 20248-KReg FD DisclosureSep 3, 202410-Q10-QJul 31, 20248-KResults of Operations · Reg FD DisclosureJul 24, 20248-KReg FD Disclosure · Company UpdateJul 15, 20248-KExecutive ChangeJul 10, 202411-K11-KJun 20, 202411-K11-KJun 20, 20248-KExecutive ChangeJun 17, 20248-KReg FD Disclosure · Company UpdateJun 3, 20248-KShareholder VoteMay 8, 202410-Q10-QApr 29, 20248-KResults of OperationsApr 25, 2024DEFA14ADEFA14AMar 26, 2024DEFA14ADEFA14AMar 26, 2024DEF 14ADEF 14AMar 26, 20248-KExecutive ChangeMar 26, 202410-K10-KFeb 12, 20248-KResults of OperationsFeb 6, 20248-KReg FD Disclosure · Company UpdateDec 7, 202310-Q10-QOct 27, 20238-KResults of OperationsOct 25, 202310-Q10-QJul 28, 20238-KResults of OperationsJul 26, 202311-K11-KJun 15, 202311-K11-KJun 15, 20238-KExecutive Change · Bylaw AmendmentMay 15, 202310-Q10-QApr 28, 20238-KResults of OperationsApr 26, 2023DEFA14ADEFA14AMar 28, 2023DEFA14ADEFA14AMar 28, 2023DEF 14ADEF 14AMar 28, 20238-KBylaw AmendmentFeb 21, 202310-K10-KFeb 13, 20238-KResults of OperationsJan 31, 20238-KExecutive Change · Reg FD DisclosureDec 8, 20228-KCompany UpdateNov 1, 202210-Q10-QOct 28, 20228-KResults of OperationsOct 27, 202210-Q10-QJul 29, 20228-KResults of OperationsJul 28, 20228-KMaterial Agreement · Agreement TerminatedJul 21, 202211-K11-KJun 16, 202211-K11-KJun 16, 20228-KShareholder VoteMay 4, 202210-Q10-QApr 28, 20228-KResults of OperationsApr 26, 2022
Insider Activity
In the 90 days to Mar 11, 2026: 6 sold $8.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Ullem Scott B.CVP, Chief Financial Officer | Sell | 7,901 | $85.21 | $673K |
| Mar 11, 2026 | Ullem Scott B.CVP, Chief Financial Officer | Sell | 5,099 | $84.46 | $431K |
| Mar 11, 2026 | Lippis Daniel J.CVP, TAVR | Sell | 1,019 | $85.38 | $87K |
| Mar 2, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 11,340 | $85.93 | $974K |
| Feb 25, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 24,000 | $83.84 | $2.0M |
| Feb 12, 2026 | Zovighian Bernard JCEO | Sell | 19,898 | $76.61 | $1.5M |
| Feb 12, 2026 | Zovighian Bernard JCEO | Sell | 2,532 | $77.13 | $195K |
| Jan 9, 2026 | Lippis Daniel J.CVP, TAVR | Sell | 1,019 | $85.70 | $87K |
| Jan 6, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 8,708 | $85.98 | $749K |
| Jan 6, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 2,632 | $84.62 | $223K |
| Dec 12, 2025 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 5,900 | $83.74 | $494K |
| Dec 12, 2025 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 5,486 | $83.79 | $460K |
| Dec 12, 2025 | Stone Heisz LeslieDirector | Sell | 2,615 | $83.41 | $218K |
| Dec 12, 2025 | Lippis Daniel J.CVP, JAPAC | Sell | 1,019 | $84.03 | $86K |
| Dec 11, 2025 | Chopra DaveenCVP, TMTT & Surgical | Sell | 2,000 | $84.38 | $169K |
| Dec 10, 2025 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 11,340 | $83.83 | $951K |
| Dec 10, 2025 | Zovighian Bernard JCEO | Sell | 3,863 | $83.45 | $322K |
| Dec 9, 2025 | Ullem Scott B.CVP, Chief Financial Officer | Sell | 7,700 | $84.47 | $650K |
| Dec 8, 2025 | Zovighian Bernard JCEO | Sell | 21,487 | $85.21 | $1.8M |
| Dec 8, 2025 | Markowitz WayneCVP, JAPAC | Sell | 583 | $86.01 | $50K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 10 reputable articles.
MarketWatchEdwards Lifesciences Corp. stock outperforms competitors on strong trading day3d agoMarketWatchEdwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors despite daily gains6d agoMarketWatchEdwards Lifesciences Corp. stock underperforms Monday when compared to competitors7d agoMarketWatchEdwards Lifesciences Corp. stock outperforms competitors despite losses on the day12d agoMarketWatchEdwards Lifesciences Corp. stock rises Monday, still underperforms market14d agoMarketWatchEdwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains25d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance